Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lawler, M.
Right arrow Articles by McCann, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lawler, M.
Right arrow Articles by McCann, S. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction

M Lawler, P Humphries and SR McCann

Department of Genetics, Trinity College, Dublin, Ireland.

The influence of mixed hematopoietic chimerism (MC) after allogeneic bone marrow transplantation remains unknown. Increasingly sensitive detection methods have shown that MC occurs frequently. We report a highly sensitive novel method to assess MC based on the polymerase chain reaction (PCR). Simple dinucleotide repeat sequences called microsatellites have been found to vary in their repeat number between individuals. We use this variation to type donor-recipient pairs following allogeneic BMT. A panel of seven microsatellites was used to distinguish between donor and recipient cells of 32 transplants. Informative microsatellites were subsequently used to assess MC after BMT in this group of patients. Seventeen of the 32 transplants involved a donor of opposite sex; hence, cytogenetics and Y chromosome-specific PCR were also used as an index of chimerism in these patients. MC was detected in bone marrow aspirates and peripheral blood in 18 of 32 patients (56%) by PCR. In several cases, only stored slide material was available for analysis but PCR of microsatellites or Y chromosomal material could be used successfully to assess the origin of cells in this archival material. Cytogenetic analysis was possible in 17 patients and MC was detected in three patients. Twelve patients received T-cell-depleted marrow and showed a high incidence of MC as revealed by PCR (greater than 80%). Twenty patients received unmanipulated marrow, and while the incidence of MC was lower (44%), this was a high percentage when compared with other studies. Once MC was detected, the percentages of recipient cells tended to increase. However, in patients exhibiting MC who subsequently relapsed, this increase was relatively sudden. The overall level of recipient cells in the group of MC patients who subsequently relapsed was higher than in those who exhibited stable MC. Thus, while the occurrence of MC was not indicative of a poor prognosis per se, sudden increases in the proportions of recipient cells may be a prelude to graft rejection or relapse.

Volume 77, Issue 11, pp. 2504-2514, 06/01/1991
Copyright © 1991 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. L. DeMeo, J. J. Reilly, L. C. Ginns, J. S. Sylvia, and E. K. Silverman
Concordance of Genotypes in Pre- and Post-Lung Transplantation DNA Samples
Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 402 - 405.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S.-Y. Kong, C.-S. Ki, H.-J. Kim, K.-o Lee, J.-c. Bae, S.-H. Kim, and J.-W. Kim
Evaluation of Imprecision for Analysis of Short Tandem Repeats by Use of Mixed Blood Cells in Variable Concentrations
Clin. Chem., November 1, 2004; 50(11): 2193 - 2195.
[Full Text] [PDF]


Home page
BloodHome page
S. R. McCann, K. Gately, E. Conneally, and M. Lawler
Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML
Blood, February 1, 2003; 101(3): 1200 - 1200.
[Full Text] [PDF]


Home page
BloodHome page
E. P. Hochberg, D. B. Miklos, D. Neuberg, D. A. Eichner, S. F. McLaughlin, A. Mattes-Ritz, E. P. Alyea, J. H. Antin, R. J. Soiffer, and J. Ritz
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation
Blood, January 1, 2003; 101(1): 363 - 369.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Bellucci, E. P. Alyea, E. Weller, A. Chillemi, E. Hochberg, C. J. Wu, C. Canning, R. Schlossman, R. J. Soiffer, K. C. Anderson, et al.
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma
Blood, May 29, 2002; 99(12): 4610 - 4617.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. J. Wu, A. Chillemi, E. P. Alyea, E. Orsini, D. Neuberg, R. J. Soiffer, and J. Ritz
Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism
Blood, January 1, 2000; 95(1): 352 - 359.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Gardiner, S. R. McCann, J. O'Riordan, M. Lawler;, H. Baurmann, C. Thiede, S. Nagel, T. Binder, A. Neubauer, W. Siegert, et al.
Chimerism Following Donor Lymphocyte Infusion for Chronic Myeloid Leukemia
Blood, April 15, 1999; 93(8): 2748 - 2749.
[Full Text] [PDF]


Home page
Stem CellsHome page
A Toren, G Rechavi, and A Nagler
Minimal residual disease post-bone marrow transplantation for hemato- oncological diseases
Stem Cells, May 1, 1996; 14(3): 300 - 311.
[Abstract]


Home page
Genome ResHome page
S Patri, L Daheron, A Kitzis, and J C Chomel
Evaluation of bone marrow transplantation efficiency by competitive PCR on Y sequences.
Genome Res., June 1, 1994; 3(6): 361 - 364.
[PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1991 by American Society of Hematology         Online ISSN: 1528-0020